Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
Conditions: Colon Cancer Interventions: Drug: Serplulimab; Drug: Capecitabine; Drug: Oxaliplatin Sponsors: Ruijin Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Eloxatin | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Xeloda